Estudo randomizado | Quimioterapia arterial de oxaliplatina com fluorouracila vs. sorafenibe no carcinoma hepatocelular avançado.

Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1) – Journal of Clinical Oncology (link para o resumo – $ para o texto completo)

Comentário no Twitter

FOHAIC-1 Trial: Arterial FOLFOX chemotherapy improved survival outcomes compared to sorafenib in advanced #HepatocellularCarcinoma 💉 https://t.co/coazeM6Tq5 #JCO #hpbcsm #LiverCancer #hccsm pic.twitter.com/QDWdSD4P7e

— Journal of Clinical Oncology (@JCO_ASCO) January 4, 2022